Logo image of BST

BLACKROCK SCIENCE & TECH TR (BST) Stock Price, Quote, News and Overview

NYSE:BST - New York Stock Exchange, Inc. - US09258G1040 - Currency: USD

38.23  -0.07 (-0.18%)

After market: 37.91 -0.32 (-0.84%)

Fundamental Rating

2

Taking everything into account, BST scores 2 out of 10 in our fundamental rating. BST was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BST have multiple concerns. BST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BST was profitable.
In the past year BST had a positive cash flow from operations.
BST had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BST reported negative operating cash flow in multiple years.
BST Yearly Net Income VS EBIT VS OCF VS FCFBST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 19.67%
ROE 19.85%
ROIC N/A
ROA(3y)-8.09%
ROA(5y)4.63%
ROE(3y)-8.04%
ROE(5y)4.83%
ROIC(3y)N/A
ROIC(5y)N/A
BST Yearly ROA, ROE, ROICBST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

In the last couple of years the Profit Margin of BST has declined.
The Operating Margin and Gross Margin are not available for BST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 6500%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y17.43%
PM growth 5Y-3.35%
GM growth 3YN/A
GM growth 5YN/A
BST Yearly Profit, Operating, Gross MarginsBST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K -10K 20K

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BST has been increased compared to 1 year ago.
Compared to 5 years ago, BST has more shares outstanding
Compared to 1 year ago, BST has an improved debt to assets ratio.
BST Yearly Shares OutstandingBST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BST Yearly Total Debt VS Total AssetsBST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BST has an Altman-Z score of 61.89. This indicates that BST is financially healthy and has little risk of bankruptcy at the moment.
BST has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
BST has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Although BST does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 61.89
ROIC/WACCN/A
WACCN/A
BST Yearly LT Debt VS Equity VS FCFBST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BST has a Current Ratio of 0.09. This is a bad value and indicates that BST is not financially healthy enough and could expect problems in meeting its short term obligations.
BST has a Quick Ratio of 0.09. This is a bad value and indicates that BST is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
BST Yearly Current Assets VS Current LiabilitesBST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for BST have decreased by -8.02% in the last year.
Measured over the past years, BST shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.82% on average per year.
BST shows a decrease in Revenue. In the last year, the revenue decreased by -3.21%.
Measured over the past years, BST shows a quite strong growth in Revenue. The Revenue has been growing by 8.06% on average per year.
EPS 1Y (TTM)-8.02%
EPS 3Y22.37%
EPS 5Y-3.82%
EPS Q2Q%6.28%
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y7.3%
Revenue growth 5Y8.06%
Sales Q2Q%17.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BST Yearly Revenue VS EstimatesBST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.90, the valuation of BST can be described as very cheap.
The average S&P500 Price/Earnings ratio is at 27.30. BST is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.9
Fwd PE N/A
BST Price Earnings VS Forward Price EarningsBST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 14.12
EV/EBITDA N/A
BST Per share dataBST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

BST has a Yearly Dividend Yield of 7.85%, which is a nice return.
BST's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 7.85%

5.2 History

The dividend of BST decreases each year by -1.74%.
BST has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BST decreased in the last 3 years.
Dividend Growth(5Y)-1.74%
Div Incr Years0
Div Non Decr Years2
BST Yearly Dividends per shareBST Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

37.36% of the earnings are spent on dividend by BST. This is a low number and sustainable payout ratio.
The Dividend Rate of BST has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP37.36%
EPS Next 2YN/A
EPS Next 3YN/A
BST Yearly Income VS Free CF VS DividendBST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M
BST Dividend Payout.BST Dividend Payout, showing the Payout Ratio.BST Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK SCIENCE & TECH TR

NYSE:BST (7/11/2025, 8:04:01 PM)

After market: 37.91 -0.32 (-0.84%)

38.23

-0.07 (-0.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners19.34%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change75.82%
Market Cap1.33B
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 7.85%
Yearly Dividend2.96
Dividend Growth(5Y)-1.74%
DP37.36%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-13 2025-06-13 (0.25)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.9
Fwd PE N/A
P/S 316.03
P/FCF 14.12
P/OCF 14.12
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)7.8
EY20.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.71
FCFY7.08%
OCF(TTM)2.71
OCFY7.08%
SpS0.12
BVpS39.6
TBVpS39.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.67%
ROE 19.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6500%
GM N/A
FCFM 2238.1%
ROA(3y)-8.09%
ROA(5y)4.63%
ROE(3y)-8.04%
ROE(5y)4.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y17.43%
PM growth 5Y-3.35%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 34.43%
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z 61.89
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.02%
EPS 3Y22.37%
EPS 5Y-3.82%
EPS Q2Q%6.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y7.3%
Revenue growth 5Y8.06%
Sales Q2Q%17.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.77%
FCF growth 3YN/A
FCF growth 5Y6.67%
OCF growth 1Y80.77%
OCF growth 3YN/A
OCF growth 5Y6.67%